
    
      In a double-blind, controlled, randomized, cross-over manner, 19 subjects with T2DM will
      receive on 2 different days beverages containing either glycated, heat-treated BLG or
      non-glycated, heat-treated BLG.

      Macrovascular (brachial ultrasound of flow mediated dilatation -FMD) and microvascular
      function (laser-doppler measurements of reactive hyperemia at the hand) at baseline (T0), as
      well as 90 (T90) and 180 (T180) minutes after each beverage will be measured.
    
  